MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$114,375K
Accounts receivable, net
$51,763K
Cash and cash
equivalents
$40,580K
Prepaid and other
current assets
$21,942K
Inventories
$11,506K
Deferred income tax asset
$245,852K
Total current assets
$240,166K
Intangible assets, net
$24,748K
Other assets
$1,908K
Operating lease
right-of-use assets
$920K
Total assets
$513,594K
Total liabilities and
stockholders equity
$513,594K
Total stockholders
equity
$391,480K
Total liabilities
$122,114K
Accumulated deficit
-$1,023,041K
Additional paid-in capital
$1,414,322K
Total current
liabilities
$99,237K
Long-term portion of loans
payable, net
$22,482K
Long-term portion of lease
liabilities
$395K
Accumulated other
comprehensive income
$181K
Common stock, 0.001 par
value 400,000,000...
$18K
Loans payable, net,
current portion
$29,812K
Revenue reserves and
refund liability
$27,716K
Accrued compensation
$11,914K
Other current
liabilities
$11,466K
Accounts payable
$7,191K
Accrued research and
development
$5,524K
Acquisition related
liabilities
$5,000K
Lease liabilities,
current portion
$614K
Back
Back
Balance Sheet
source: myfinsight.com
RIGEL PHARMACEUTICALS INC (RIGL)
RIGEL PHARMACEUTICALS INC (RIGL)